Monday, April 4, 2016

BRIEF-Conformis says FDA raised a number of questions on iTotal Hip

* FDA raised a number of questions on iTotal Hip

application, Conformis was not able to address all of those

questions within allowed review timeline

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)